Dimensional Fund Advisors LP Organogenesis Holdings Inc. Transaction History
Dimensional Fund Advisors LP
- $405 Billion
- Q4 2024
A detailed history of Dimensional Fund Advisors LP transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,789,265 shares of ORGO stock, worth $14.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,789,265
Previous 2,346,493
18.87%
Holding current value
$14.4 Million
Previous $6.71 Million
33.01%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ORGO
# of Institutions
124Shares Held
62MCall Options Held
4.3KPut Options Held
3.9K-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$64.4 Million2.78% of portfolio
-
Morgan Stanley New York, NY11.8MShares$61 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$26.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$18.5 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.08MShares$15.9 Million0.03% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $675M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...